These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 25638532)

  • 1. Evolving brain structural changes in PSEN1 mutation carriers.
    Sala-Llonch R; Lladó A; Fortea J; Bosch B; Antonell A; Balasa M; Bargalló N; Bartrés-Faz D; Molinuevo JL; Sánchez-Valle R
    Neurobiol Aging; 2015 Mar; 36(3):1261-70. PubMed ID: 25638532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased cortical thickness and caudate volume precede atrophy in PSEN1 mutation carriers.
    Fortea J; Sala-Llonch R; Bartrés-Faz D; Bosch B; Lladó A; Bargalló N; Molinuevo JL; Sánchez-Valle R
    J Alzheimers Dis; 2010; 22(3):909-22. PubMed ID: 20858974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolving brain functional abnormalities in PSEN1 mutation carriers: a resting and visual encoding fMRI study.
    Sala-Llonch R; Fortea J; Bartrés-Faz D; Bosch B; Lladó A; Peña-Gómez C; Antonell A; Castellanos-Pinedo F; Bargalló N; Molinuevo JL; Sánchez-Valle R
    J Alzheimers Dis; 2013; 36(1):165-75. PubMed ID: 23579331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.
    Balasa M; Vidal-Piñeiro D; Lladó A; Antonell A; Bosch B; Castellanos F; Bargalló N; Bartres-Faz D; Molinuevo JL; Sánchez-Valle R
    J Alzheimers Dis; 2012; 30(3):605-16. PubMed ID: 22426017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acceleration of cortical thinning in familial Alzheimer's disease.
    Knight WD; Kim LG; Douiri A; Frost C; Rossor MN; Fox NC
    Neurobiol Aging; 2011 Oct; 32(10):1765-73. PubMed ID: 20005601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.
    Londono AC; Castellanos FX; Arbelaez A; Ruiz A; Aguirre-Acevedo DC; Richardson AM; Easteal S; Lidbury BA; Arcos-Burgos M; Lopera F
    Alzheimers Dement; 2014 Sep; 10(5):552-61. PubMed ID: 24239247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cortical atrophy in presymptomatic Alzheimer's disease presenilin 1 mutation carriers.
    Quiroz YT; Stern CE; Reiman EM; Brickhouse M; Ruiz A; Sperling RA; Lopera F; Dickerson BC
    J Neurol Neurosurg Psychiatry; 2013 May; 84(5):556-61. PubMed ID: 23134660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presymptomatic cortical thinning in familial Alzheimer disease: A longitudinal MRI study.
    Weston PS; Nicholas JM; Lehmann M; Ryan NS; Liang Y; Macpherson K; Modat M; Rossor MN; Schott JM; Ourselin S; Fox NC
    Neurology; 2016 Nov; 87(19):2050-2057. PubMed ID: 27733562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease.
    Thordardottir S; Ståhlbom AK; Ferreira D; Almkvist O; Westman E; Zetterberg H; Eriksdotter M; Blennow K; Graff C
    J Alzheimers Dis; 2015; 43(4):1393-402. PubMed ID: 25182737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cortical microstructural correlates of astrocytosis in autosomal-dominant Alzheimer disease.
    Vilaplana E; Rodriguez-Vieitez E; Ferreira D; Montal V; Almkvist O; Wall A; Lleó A; Westman E; Graff C; Fortea J; Nordberg A
    Neurology; 2020 May; 94(19):e2026-e2036. PubMed ID: 32291295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional brain volume differences in symptomatic and presymptomatic carriers of familial Alzheimer's disease mutations.
    Lee GJ; Lu PH; Medina LD; Rodriguez-Agudelo Y; Melchor S; Coppola G; Braskie MN; Hua X; Apostolova LG; Leow AD; Thompson PM; Ringman JM
    J Neurol Neurosurg Psychiatry; 2013 Feb; 84(2):154-62. PubMed ID: 23085935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study.
    Quiroz YT; Schultz AP; Chen K; Protas HD; Brickhouse M; Fleisher AS; Langbaum JB; Thiyyagura P; Fagan AM; Shah AR; Muniz M; Arboleda-Velasquez JF; Munoz C; Garcia G; Acosta-Baena N; Giraldo M; Tirado V; Ramírez DL; Tariot PN; Dickerson BC; Sperling RA; Lopera F; Reiman EM
    JAMA Neurol; 2015 Aug; 72(8):912-9. PubMed ID: 26121081
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced brain activity may precede the diagnosis of Alzheimer's disease by 30 years.
    Mondadori CR; Buchmann A; Mustovic H; Schmidt CF; Boesiger P; Nitsch RM; Hock C; Streffer J; Henke K
    Brain; 2006 Nov; 129(Pt 11):2908-22. PubMed ID: 17012294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study.
    Acosta-Baena N; Sepulveda-Falla D; Lopera-Gómez CM; Jaramillo-Elorza MC; Moreno S; Aguirre-Acevedo DC; Saldarriaga A; Lopera F
    Lancet Neurol; 2011 Mar; 10(3):213-20. PubMed ID: 21296022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of gene mutation and disease progression on representative neural circuits in familial Alzheimer's disease.
    Quan M; Zhao T; Tang Y; Luo P; Wang W; Qin Q; Li T; Wang Q; Fang J; Jia J
    Alzheimers Res Ther; 2020 Jan; 12(1):14. PubMed ID: 31937364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffusion tensor imaging in preclinical and presymptomatic carriers of familial Alzheimer's disease mutations.
    Ringman JM; O'Neill J; Geschwind D; Medina L; Apostolova LG; Rodriguez Y; Schaffer B; Varpetian A; Tseng B; Ortiz F; Fitten J; Cummings JL; Bartzokis G
    Brain; 2007 Jul; 130(Pt 7):1767-76. PubMed ID: 17522104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regional patterns of 18F-florbetaben uptake in presenilin 1 mutation carriers.
    Sala-Llonch R; Falgàs N; Bosch B; Fernández-Villullas G; Balasa M; Antonell A; Perissinotti A; Pavía J; Campos F; Lladó A; Lomeña F; Sánchez-Valle R
    Neurobiol Aging; 2019 Sep; 81():1-8. PubMed ID: 31207465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early-onset Alzheimer's disease with a de novo mutation in the presenilin 1 gene.
    Golan MP; Styczyńska M; Jóźwiak K; Walecki J; Maruszak A; Pniewski J; Lugiewicz R; Filipek S; Zekanowski C; Barcikowska M
    Exp Neurol; 2007 Dec; 208(2):264-8. PubMed ID: 17931627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinctive age-related temporal cortical thinning in asymptomatic granulin gene mutation carriers.
    Moreno F; Sala-Llonch R; Barandiaran M; Sánchez-Valle R; Estanga A; Bartrés-Faz D; Sistiaga A; Alzualde A; Fernández E; Martí Massó JF; López de Munain A; Indakoetxea B
    Neurobiol Aging; 2013 May; 34(5):1462-8. PubMed ID: 23218900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measuring cortical mean diffusivity to assess early microstructural cortical change in presymptomatic familial Alzheimer's disease.
    Weston PSJ; Poole T; Nicholas JM; Toussaint N; Simpson IJA; Modat M; Ryan NS; Liang Y; Rossor MN; Schott JM; Ourselin S; Zhang H; Fox NC
    Alzheimers Res Ther; 2020 Sep; 12(1):112. PubMed ID: 32943095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.